Literature DB >> 22354873

Analysis of p16(INK4A) expression of oral squamous cell carcinomas in Taiwan: prognostic correlation without relevance to betel quid consumption.

Ya-Wei Chen1, Shou-Yen Kao, Muh-Hwa Yang.   

Abstract

OBJECTIVES: In this study, we examined the role of p16(INK4A) , a surrogate biomarker of HPV-related head and neck cancers with better prognosis, in an endemic area of betel quid (BQ)-related oral squamous cell carcinoma (OSCC).
METHODS: p16(INK4A) immunohistochemistry was examined in 165 OSCCs, statistical analyses were performed to elucidate the correlation between p16(INK4A) expression and BQ habits/pathologic features, and the prognostic impact of p16(INK4A) and different parameters were analyzed.
RESULTS: The incidence of p16(INK4A) expression was similar between BQ chewers and non-chewers. p16(INK4A) expression was significantly associated with nodal metastasis (P = 0.005). There was a trend suggesting that the loss of p16(INK4A) expression was more frequent in higher T stages, however, this was found only in patients without lymph node metastasis (P = 0.059). A poorer prognosis and a higher risk of tumor recurrence were found in OSCCs without p16(INK4A) expression. (The HR for cancer-specific mortality and cancer recurrence was 3.55 and 1.89, respectively.)
CONCLUSION: Although it has been suggested that BQ chewers had a greater tendency toward tumor recurrence and poor outcome, our data demonstrated that p16(INK4A) expression is unrelated to BQ habit and that p16(INK4A) downregulation is a strong predictor for OSCC progression, recurrence and survival in Taiwan.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22354873     DOI: 10.1002/jso.23067

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathways.

Authors:  Tatyana Isayeva; Jie Xu; Camille Ragin; Qian Dai; Tiffiny Cooper; William Carroll; Dan Dayan; Marilena Vered; Bruce Wenig; Eben Rosenthal; William Grizzle; Joshua Anderson; Christopher D Willey; Eddy S Yang; Margaret Brandwein-Gensler
Journal:  Mod Pathol       Date:  2014-12-19       Impact factor: 7.842

Review 2.  The role of human papillomavirus in oral squamous cell carcinoma: myth and reality.

Authors:  Katinka Kansy; Oliver Thiele; Kolja Freier
Journal:  Oral Maxillofac Surg       Date:  2012-12-16

3.  Modified weekly cisplatin-based chemotherapy is acceptable in postoperative concurrent chemoradiotherapy for locally advanced head and neck cancer.

Authors:  Hsueh-Ju Lu; Chao-Chun Yang; Ling-Wei Wang; Pen-Yuan Chu; Shyh-Kuan Tai; Ming-Huang Chen; Muh-Hwa Yang; Peter Mu-Hsin Chang
Journal:  Biomed Res Int       Date:  2015-02-22       Impact factor: 3.411

4.  PD-L1 expression is associated with p16INK4A expression in non-oropharyngeal head and neck squamous cell carcinoma.

Authors:  San-Chi Chen; Peter Mu-Hsin Chang; Hsiao-Jung Wang; Shyh-Kuan Tai; Pen-Yuan Chu; Muh-Hwa Yang
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

5.  Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: a propensity score matching analysis.

Authors:  Kang-Hsing Fan; Yen-Chao Chen; Chien-Yu Lin; Chung-Jan Kang; Li-Yu Lee; Shiang-Fu Huang; Chun-Ta Liao; Shu-Hang Ng; Hung-Ming Wang; Joseph Tung-Chieh Chang
Journal:  Radiat Oncol       Date:  2017-11-22       Impact factor: 3.481

6.  Demographic Profile of p16 Immunopositive and HPV DNA PCR Positive Oral Squamous Cell Carcinoma in a Large Cohort of Indian Patients.

Authors:  Farhat Naz; Hitesh Verma; Nadeem Tanveer; Arava Kumar Sudheer; Aanchal Kakkar; Pranay Tanwar
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

7.  Differential impact of IL-10 expression on survival and relapse between HPV16-positive and -negative oral squamous cell carcinomas.

Authors:  Chun-Yi Chuang; Wen-Wei Sung; Lee Wang; Wea-Long Lin; Kun-Tu Yeh; Mao-Chang Su; Chun-Han Hsin; Shiann-Yann Lee; Buor-Chang Wu; Ya-Wen Cheng; Huei Lee
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.